newsfilter
← Latest News
PR Newswire·

Lipocine's LPCN 1148 Highlighted in the June 2025 Edition of Hepatology

Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective...